Yale Medicine School: Adapting to the Changing Liver Cancer Landscape
February 26, 2021
February 26, 2021
NEW HAVEN, Connecticut, Feb. 26 (TNSRes) -- Yale School of Medicine issued the following news:
In the United States, hepatitis C has long been the number one driver of hepatocellular carcinoma (HCC), the most common liver cancer and the fourth-leading cause of cancer-related deaths worldwide. Between three to five million Americans are living with chronic hepatitis C, but 4 in 10 do not realize they have it. More than 75 percent of patients are baby boomers, whose many years of unde . . .
In the United States, hepatitis C has long been the number one driver of hepatocellular carcinoma (HCC), the most common liver cancer and the fourth-leading cause of cancer-related deaths worldwide. Between three to five million Americans are living with chronic hepatitis C, but 4 in 10 do not realize they have it. More than 75 percent of patients are baby boomers, whose many years of unde . . .